DE NICOLAO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 12.466
AS - Asia 8.772
EU - Europa 7.658
SA - Sud America 950
AF - Africa 251
Continente sconosciuto - Info sul continente non disponibili 197
OC - Oceania 16
AN - Antartide 1
Totale 30.311
Nazione #
US - Stati Uniti d'America 12.188
CN - Cina 4.579
SG - Singapore 1.965
IE - Irlanda 1.549
UA - Ucraina 1.133
HK - Hong Kong 877
DE - Germania 796
FI - Finlandia 755
RU - Federazione Russa 713
BR - Brasile 680
VN - Vietnam 584
NL - Olanda 523
IT - Italia 492
SE - Svezia 485
FR - Francia 460
GB - Regno Unito 457
IN - India 178
CA - Canada 132
ZA - Sudafrica 123
BD - Bangladesh 89
AR - Argentina 86
MX - Messico 80
IQ - Iraq 78
BE - Belgio 54
PL - Polonia 52
TR - Turchia 49
JP - Giappone 47
EC - Ecuador 44
CO - Colombia 41
PK - Pakistan 41
ES - Italia 35
MA - Marocco 34
MY - Malesia 30
ID - Indonesia 29
UZ - Uzbekistan 29
VE - Venezuela 29
AT - Austria 27
PT - Portogallo 25
PH - Filippine 23
SA - Arabia Saudita 22
CL - Cile 21
AZ - Azerbaigian 18
JO - Giordania 18
PY - Paraguay 18
JM - Giamaica 15
LT - Lituania 15
EU - Europa 14
TN - Tunisia 14
AU - Australia 13
IR - Iran 13
BO - Bolivia 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
EG - Egitto 11
SK - Slovacchia (Repubblica Slovacca) 11
NP - Nepal 10
CZ - Repubblica Ceca 9
KE - Kenya 9
KG - Kirghizistan 9
CH - Svizzera 8
ET - Etiopia 8
HN - Honduras 8
KR - Corea 8
TH - Thailandia 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
GR - Grecia 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
AL - Albania 6
BY - Bielorussia 6
CR - Costa Rica 6
KW - Kuwait 6
NG - Nigeria 6
NO - Norvegia 6
RO - Romania 6
SN - Senegal 6
GT - Guatemala 5
LV - Lettonia 5
LY - Libia 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
UY - Uruguay 5
IL - Israele 4
PR - Porto Rico 4
SV - El Salvador 4
GA - Gabon 3
GE - Georgia 3
HU - Ungheria 3
IS - Islanda 3
LB - Libano 3
NI - Nicaragua 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DK - Danimarca 2
LK - Sri Lanka 2
Totale 30.083
Città #
Chandler 1.580
Dublin 1.548
Jacksonville 1.339
San Jose 1.145
Nanjing 1.099
Singapore 1.009
Ashburn 956
Hong Kong 841
Dallas 699
Boardman 645
Beijing 641
Nanchang 423
Council Bluffs 411
Princeton 327
Shenyang 306
Lawrence 296
Wilmington 289
Hebei 285
Lauterbourg 282
Los Angeles 281
Changsha 266
Jiaxing 255
Ann Arbor 236
Medford 219
Ho Chi Minh City 210
Helsinki 169
Tianjin 156
Buffalo 152
Hangzhou 151
Milan 146
Hanoi 130
Moscow 129
Woodbridge 119
Shanghai 117
New York 108
Piscataway 106
Santa Clara 99
Johannesburg 97
Munich 95
Redondo Beach 88
Dearborn 81
Verona 65
São Paulo 64
Orem 61
Norwalk 60
Seattle 53
Chicago 52
Brussels 48
Toronto 48
Frankfurt am Main 46
Pavia 46
The Dalles 45
Houston 44
Tokyo 39
Guangzhou 38
Turku 37
Warsaw 37
Des Moines 36
Kunming 34
Montreal 33
Falkenstein 32
Mexico City 32
Rome 31
London 30
San Francisco 30
Zhengzhou 30
Jinan 29
Brooklyn 28
Atlanta 26
Tashkent 26
Boston 25
Fairfield 25
Baghdad 23
Chennai 23
Da Nang 23
Dong Ket 23
Ningbo 23
Stockholm 23
Amsterdam 22
Manchester 22
Poplar 22
Rio de Janeiro 22
Denver 21
Washington 21
Nuremberg 20
Salvador 20
Columbus 19
Mumbai 19
Amman 18
Guayaquil 17
Hải Dương 17
Phoenix 17
Pune 17
Haiphong 16
Kuala Lumpur 16
Quito 16
Auburn Hills 15
Dhaka 15
Taizhou 15
Baku 14
Totale 19.300
Nome #
Steady-state equivalence of drug- and biomarker driven models in tumor growth experiments 593
Diabetes: Models, signals and control 232
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis 187
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 181
Artificial pancreas: Model predictive control design from clinical experience 171
A Bayesian approach to non-parametric AUC estimation in population studies 169
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 158
A stabilizing model-based predictive control for nonlinear systems 153
MPC-based artificial pancreas: Strategies for individualization and meal compensation 152
Population Pharmacokinetic Model of Ibrutinib, a BTK Inhibitor for the Treatment of B-cell malignancies 147
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 146
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab. 145
A Bayesian nonparametric approach to AUC determination in population studies 140
A mathematical model to study the effects of drugs administration on tumor growth dynamics 140
A PCA approach to population analysis: with application to a Phase II depression trial 137
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement 137
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 136
PCA-based modelling in antidepressant trials: a pre-mechanistic approach 136
Adaptive Controllers for Intelligent Monitoring 135
Multistep virtual metrology approaches for semiconductor manufacturing processes 135
Methods and tools for multiscale modelling in Systems Pharmacology: a review 135
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases. 134
A Kalman filtering algorithm for regularization networks 134
Continuous-time Markov modelling of flexible-dose depression trials 133
Bayesian population approaches to the analysis of dose escalation studies 133
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 132
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 132
Counting events: population approaches using NONMEM 131
Model predictive control: output feedback and tracking of nonlinear systems 128
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia 127
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 127
Multi-step virtual metrology for semiconductor manufacturing: A multilevel and regularization methods-based approach 127
Modeling myelosuppression in patients treated with anticancer drugs 126
Second order Markov modelling of HAMD responses in depression trials 126
Heart rate correction of the QT interval: a nonparametric individualized approach 125
Predicting the active doses in humans from animal studies: A novel approach in oncology 125
A nonparametric approach for model individualization in an artificial pancreas 125
Some comments on nu-Support Vector Machines 124
Second-order indirect response modelling of complex biomarker dynamics 124
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies 124
Fast calibration of two-factor models for energy option pricing 124
ACID: Automatic classification of sort test maps for interactive process diagnosis 122
Identification and idle speed control of internal combustion engines 122
A hidden-Gamma model-based filtering and prediction approach for monotonic health factors in manufacturing 122
Process Diagnosis via Electrical-Wafer-Sorting Maps Classification 121
Particle filtering of hidden Gamma processes for robust Predictive Maintenance in semiconductor manufacturing 121
Population state-space modelling of patient responses in antidepressant studies 121
An information-theory and Virtual Metrology-based approach to Run-to-Run semiconductor manufacturing control 120
Kernel methods in system identification, machine learning and function estimation: A survey 119
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 118
Tumor growth modelling for drug development 118
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 118
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 118
Proportional Hazard Model with L1 Penalization applied to Predictive Maintenance in Semiconductor Manufacturing 117
A collision risk assessment approach as a basis for the on-board warning generation in cars 117
Nonparametric identification of pharmacokinetic population models via Gaussian processes 116
H-infinity differential Riccati equations: convergence properties and finite escape phenomena 116
A new kernel-based approach for linear system identification 116
A state-space approach to disease and dropout modelling in Phase II clinical trials 116
A New Neural Network Approach for Short-Term Glucose Prediction Using Continuous Glucose Monitoring Time-Series and Meal Information 116
Model Predictive Control of Type 1 diabetes added to conventional therapy 116
A PK-PD model for predicting tumor growth inhibition in mice: a useful tool in oncology drug development 116
Multilevel kernel methods for virtual metrology in semiconductor manufacturing 115
A new, second-order indirect model of depression time course 115
H_infinity-robustness of adaptive filters against measurement noise and parameter drift 114
Nonparametric identification of population models via Gaussian processes 114
A mininal model of tumor growth inhibition 114
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 114
MPC based Artificial Pancreas: Strategies for individualization and meal compensation 114
Multilevel statistical process control of asynchronous multi-stream processes in semiconductor manufacturing 114
Population modeling of tumor growth inhibition in vivo: application to anticancer drug development 113
Disease and dropout modelling in depression trials: a state-space approach 113
AC/ID: a Wafer Oriented Process Diagnosis Techniques 113
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture 113
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues 113
An Algebraic Characterization of the Optimum of Regularized Kernel Methods 113
A new kernel-based approach for system identification 112
Nonparametric modelling of in vitro antitumor pharmacodynamic studies to optimize drug concentration and treatment time 111
Bayesian online multi-task learning of Gaussian processes 111
Nonparametric input estimation in physiological systems: Problems, methods, case studies 110
A model based approach to the in vitro evaluation of anticancer activity 110
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administrations of anticancer agents 110
A Novel Nonparametric Approach for the Identification of the Glucose-Insulin System in Type 1 Diabetic Patients 110
Population modeling of tumor growth in untreated xenografted mice 109
A new statistical algorithmm to enhance volume diagnostic effectiveness and accuracy 109
Dose escalation studies in Phase I clinical trials: a comparison among Bayesian population approaches 109
A multi-task learning approach for the extraction of single-trial evoked potentials 109
Model predictive control of type 1 diabetes: An in silico trial 109
Current mathematical models for cancer drug discovery 109
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 109
PK/PD modeling of tumor growth inhibition in vivo 108
Method to evaluate the systemic exposure in toxicological and pharmacological studies 108
Modeling of human tumor xenografts and dose rationale in oncology 108
A letter on Ancaiani et al. ‘Evaluating scientific research in Italy: the 2004-10 research evaluation exercise’ 108
Re: Antitumor Efficacy Testing in Rodents 107
Modelling of the outcome of non-inferiority trials by integration of historical data 107
An EKF-based algorithm for automatic tuning and control of electrical drives 107
Output feedback and tracking of nonlinear systems with model predictive control 107
On the zeros of discrete-time linear periodic systems 106
A minimal model describing the effect of drug administration on tumor growth dynamics 106
Totale 12.913
Categoria #
all - tutte 127.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.701 0 11 39 20 17 39 22 81 66 29 221 1.156
2022/20234.519 496 310 66 350 543 435 8 238 1.858 31 130 54
2023/20241.537 179 231 75 111 152 328 57 133 13 45 138 75
2024/20253.995 92 401 81 173 131 138 137 373 968 92 436 973
2025/20269.145 700 604 1.031 796 1.146 408 1.782 331 760 813 376 398
2026/2027703 182 521 0 0 0 0 0 0 0 0 0 0
Totale 30.311